Mimedx (MDXG) Change in Accured Expenses (2011 - 2026)

Mimedx (MDXG) has 16 years of Change in Accured Expenses data on file, last reported at -$15.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 21415.07% year-over-year to -$15.7 million; the trailing twelve-month figure through Mar 2026 stood at -$13.3 million (down 470.65% YoY), and the FY2025 full-year result was $2.4 million, up 400.51% from the prior year.
• Change in Accured Expenses retreated to -$15.7 million in Q1 2026, from -$1.4 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $7.2 million in Q2 2022 to a low of -$15.7 million in Q1 2026.
• A 5-year average of -$926882.4 and a median of -$269000.0 in 2024 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses jumped 2246.59% in 2022 and tumbled 21415.07% in 2026, its largest moves.
• Tracing MDXG's Change in Accured Expenses over 5 years: stood at -$1.6 million in 2022, then slumped by 122.49% to -$3.6 million in 2023, then surged by 114.23% to $518000.0 in 2024, then plunged by 378.19% to -$1.4 million in 2025, then slumped by 989.94% to -$15.7 million in 2026.
• Business Quant data shows MDXG's Change in Accured Expenses at -$15.7 million in Q1 2026, -$1.4 million in Q4 2025, and $4.9 million in Q3 2025.